Brinker Capital Inc. increased its position in shares of Cognex Co. (NASDAQ:CGNX) by 44.3% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 47,576 shares of the scientific and technical instruments company’s stock after purchasing an additional 14,613 shares during the quarter. Brinker Capital Inc.’s holdings in Cognex were worth $2,420,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in CGNX. Vanguard Group Inc. grew its holdings in Cognex by 0.7% during the 3rd quarter. Vanguard Group Inc. now owns 14,774,139 shares of the scientific and technical instruments company’s stock worth $824,693,000 after acquiring an additional 101,127 shares during the last quarter. Vanguard Group Inc grew its holdings in Cognex by 0.7% during the 3rd quarter. Vanguard Group Inc now owns 14,774,139 shares of the scientific and technical instruments company’s stock worth $824,693,000 after acquiring an additional 101,127 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in Cognex by 2.7% during the 4th quarter. Bank of New York Mellon Corp now owns 8,760,670 shares of the scientific and technical instruments company’s stock worth $338,776,000 after acquiring an additional 231,403 shares during the last quarter. Eagle Asset Management Inc. grew its holdings in Cognex by 12.0% during the 4th quarter. Eagle Asset Management Inc. now owns 3,679,715 shares of the scientific and technical instruments company’s stock worth $142,294,000 after acquiring an additional 395,461 shares during the last quarter. Finally, Neuberger Berman Group LLC grew its holdings in Cognex by 5.0% during the 3rd quarter. Neuberger Berman Group LLC now owns 3,560,339 shares of the scientific and technical instruments company’s stock worth $198,738,000 after acquiring an additional 168,345 shares during the last quarter. Institutional investors and hedge funds own 95.64% of the company’s stock.

In other news, Director Theodor Krantz sold 30,000 shares of the firm’s stock in a transaction dated Tuesday, February 26th. The shares were sold at an average price of $53.18, for a total value of $1,595,400.00. Following the transaction, the director now owns 52,500 shares of the company’s stock, valued at approximately $2,791,950. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 5.60% of the stock is currently owned by company insiders.

A number of equities research analysts have commented on CGNX shares. Zacks Investment Research raised shares of Cognex from a “hold” rating to a “buy” rating and set a $43.00 price objective on the stock in a report on Thursday, January 3rd. BidaskClub raised shares of Cognex from a “sell” rating to a “hold” rating in a report on Wednesday, January 9th. Needham & Company LLC reissued a “buy” rating and set a $50.00 price objective (up previously from $47.00) on shares of Cognex in a report on Tuesday, February 12th. Finally, ValuEngine raised shares of Cognex from a “sell” rating to a “hold” rating in a research note on Monday, February 25th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and six have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $50.10.

Shares of NASDAQ CGNX opened at $56.15 on Thursday. The stock has a market capitalization of $9.74 billion, a PE ratio of 45.28, a price-to-earnings-growth ratio of 3.01 and a beta of 1.99. Cognex Co. has a 1 year low of $34.88 and a 1 year high of $59.18.

Cognex (NASDAQ:CGNX) last issued its earnings results on Thursday, February 14th. The scientific and technical instruments company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.04. The company had revenue of $193.29 million for the quarter, compared to analyst estimates of $184.82 million. Cognex had a net margin of 27.19% and a return on equity of 19.75%. The company’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter last year, the firm earned ($0.16) EPS. On average, sell-side analysts expect that Cognex Co. will post 1.26 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Cognex Co. (CGNX) Position Raised by Brinker Capital Inc.” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international copyright laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2019/04/25/cognex-co-cgnx-position-raised-by-brinker-capital-inc.html.

Cognex Profile

Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. It provides machine vision products, which are used to automate the manufacture and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Recommended Story: Do stock splits help investors?

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Co. (NASDAQ:CGNX).

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.